Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 4 43-4, 1998, Pages

  Hyman, Albert L ^a   Hao, Qingzhong ^b   Tower, Allen ^b   Kadowitz, Philip J ^a   Champion, Hunter C ^a   Gumusel, Bulent ^b   Lippton, Howard ^b,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Nu Med Incorporated   (United States)

Author keywords

Adrenomedullin; Endothelium derived relaxing factor dependent vasodilation; Nitric oxide; Pressure flow relationship; Pulmonary vascular bed

Indexed keywords

ADRENOMEDULLIN; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; FLOW RATE; HEART ATRIUM PRESSURE; HEART CATHETERIZATION; HEMODYNAMIC MONITORING; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0031923176     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.4.h1218     Document Type: Article

References (45)

1. Abman, S. H., B. A. Chatfield, S. L., Hall, and I. F. McMurtry. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1921-H1927, 1990.
2. Aisaka, K., S. S. Gross, O. W. Griffith, and R. Levi. L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem. Biophys. Res. Commun. 163: 710-717, 1989.
3. Archer, S. L., and V. Hampl. N-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem. Biophys. Res. Commun. 188: 590-596, 1992.
4. Archer, S. L., J. P. Tolins, L. Raij, and E. K. Weir. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of endothelium derived relaxing factors. Biochem. Biophys. Res. Commun. 164: 1198-1205, 1989.
5. Barnard, J. W., P. S. Wilson, T. M. Moore, W. J. Thompson, and A. E. Taylor. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J. Appl. Physiol. 74: 2940-2948, 1993.
6. Barer, G., C. Emery, A. Stewart, D. Bell, and P. Howard. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J. Physiol. Paris 463: 1-16, 1993.
7. Bashers, V. L., M. J. Peach, and C. E. Rose, Jr. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest. 82: 1495-1502, 1988.
8. Berthiaume, N., A. Claing, H. Lippton, A. Cadieux, and P. D'Orleans-Juste. Rat adrenomedullin induces a selective arterial vasodilation via CGRP1 receptors in the double-perfused mesenteric bed of the rat. Can. J. Physiol. Pharmacol. 73: 1080-1083, 1995.
9. G nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72: 387-395, 1993.
10. Crawley, D. E., S. F. Liu, T. W. Evans, and P. J. Barnes. Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br. J. Pharmacol. 101: 166-170, 1990.
11. Dinh-Xuan, A. T., T. W. Higenbottam, C. A. Chelland, J. Pepke-Zaba, G. Cremona, A. Y. Butt, S. R. Large, F. C. Wells, and J. Wallwork. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324: 1539-1547, 1991.
12. Elhawary, A. M., J. Poon, and C. C. Pang. Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin. Br. J. Pharmacol. 115: 1133-1140, 1995.
13. ω-nitro-L-arginme methyl ester, LY 83583, glybenclamide, and L158809 on pulmonary circulation. Eur. J. Pharmacol. 263: 133-140, 1994.
14. Fineman, J. R., R. Chang, and S. J. Soifer. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1365-H1371, 1992.
15. Fineman, J. R., M. R. Crowley, M. A. Heymann, and S. J. Soifer. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. J. Appl. Physiol. 71: 735-741, 1991.
16. ω-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1299-H1306, 1991.
17. Fishman, A. P. Dynamics of the pulmonary circulation. In: Handbook of Physiology. Circulation. Washington, DC: Am. Physiol. Soc., sect. 2, vol. II, chapt. 48, p. 1687, 1963.
18. G-nitro-L-arginine methyl ester. Br. J. Pharmacol. 101: 632-639, 1990.
19. 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. Br. J. Pharmacol. 114: 592-597, 1995.
20. Hassessian, H., and G. Burnstock. Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat. Br. J. Pharmacol. 114: 846-850, 1995.
21. Hasunuma, K., T. Yamaguchi, D. M. Rodman, R. F. O'Brien, and I. F. McMurtry. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lung. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L97-L104, 1991.
22. Hyman, A. L. Effects of large increases in pulmonary blood flow on pulmonary venous pressure. J. Appl. Physiol. 27: 179-185, 1969.
23. Hyman, A. L. The effects of bradykinin on the pulmonary veins. J. Pharmacol. Exp. Ther. 161: 78-87, 1968.
24. 2 in intact-chest cats. J. Appl. Physiol. 54: 1009-1016, 1981.
25. Ignarro, L. J., R. E. Byrns, and K. S. Woods. Endothelium dependent modulation of a cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ. Res. 160: 82-92, 1987.
26. Isaacson, T. C., V. Hampl, E. K. Weir, D. P. Nelson, and S. L. Archer. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J. Appl. Physiol. 76: 933-940, 1994.
27. Linehan, J. H., and C. S. Dawson. Pulmonary vascular resistance (P:Q relations). In: The Pulmonary Circulation: Normal and Abnormal, edited by A. P. Fishman. Philadelphia, PA: Univ. of Pennsylvania Press, 1990, p. 41-55.
28. Lippton, H. L., Q. Hao, and A. Hyman. L-NAME enhances pulmonary vasoconstriction without inhibiting EDRF-dependent vasodilation. J. Appl. Physiol. 73: 2432-2439, 1992.
29. Liu, S. F., D. E. Crawley, P. J. Barnes, and T. W. Evans. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143: 32-37, 1991.
30. ω-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J. Appl. Physiol. 71: 2026-2031, 1991.
31. 2 mechanisms of guanylate cyclase activation in oxygen-dependent responses of rat pulmonary circulation. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L546-L550, 1995.
32. Moncada, S., D. D. Rees, R. Schulz, and R. J. M. Palmer. Development and mechanisms of the specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA 88: 2166-2170, 1995.
33. ω-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1331-H1337, 1992.
34. Nossaman, B. D., C. J. Feng, A. D. Kaye, B. DeWitt, D. H. Coy, W. A. Murphy, and P. J. Kadowitz. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L782-L789, 1996.
35. Nossaman, B. D., C. J. Feng, and P. J. Kadowitz. Analysis of responses to bradykinin and influence of HOE 140 in the isolated perfused rat lung. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2452-H2461, 1994.
36. Oka, M., K. Hasunuma, S. Webb, T. J. Stelzner, D. M. Rodman, and I. F. McMurtry. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am. J. Physiol. 264 (Lung Cell. Mol. Physiol. 8): L587-L597, 1993.
37. Pennutt, S., P. Caldini, S. Marri, W. H. Palmer, T. Sasamori, and K. Zichler. Recruitment versus distensibility in the pulmonary vascular bed. In: The Pulmonary Circulation and Interstitial Space, edited by A. P. Fishman and H. H. Hecht. Chicago, IL: Univ. of Chicago Press, 1969, p. 375-387.
38. Perrella, M. A., F. L. Hildebrand, K. B. Margulies, and J. C. Burnett. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R323-R328, 1991.
39. Persson, M. G., L. E. Gustafsson, N. P. Kiklund, S. Moncada, and P. Hedquist. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor in vivo. Acta Physiol. Scand. 140: 449-457, 1990.
40. Russ, R. D., and B. R. Walker. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H743-H747, 1992.
41. Russell, P. C., C. J. Emery, Y. N. Cai, G. R. Barer, and P. Howard. Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats. Eur. Respir. J. 3: 779-785, 1990.
42. Stamler, J. S., E. Loh, M. A. Roddy, K. E. Currie, and M. A. Creager. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035-2040, 1994.
43. Tjen-A-Looi, S., R. Ekman, H. Lippton, J. Cary, and I. Keith. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H681-H690, 1992.
44. Whittle, B. J., J. Lopez-Belmonte, and D. D. Rees. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P, and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 98: 646-652, 1989.
45. Zhao, L., D. E. Crawley, J. M. Hughes, T. W. Evans, and R. J. Winter. Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. J. Appl. Physiol. 74: 1061-1065, 1993.